Inogen (INGN) Long-Term Deferred Tax (2013 - 2024)
Inogen (INGN) reported Long-Term Deferred Tax of $75.7 million for Q4 2024, up 5.94% year-over-year from $71.5 million in Q1 2024, and up 5.94% quarter-over-quarter from $71.5 million in Q4 2023.
Inogen (INGN) Long-Term Deferred Tax (2013 - 2024) Analysis & Trends
Inogen (INGN) has 12 years of Long-Term Deferred Tax data on file, last reported at $75.7 million in Q4 2024.
- Long-Term Deferred Tax for Q4 2024 came in at $75.7 million, up 5.94% year-over-year; the trailing twelve-month figure through Dec 2024 was $75.7 million (up 5.94% YoY), and the FY2024 annual result was $75.7 million, up 5.94% from the prior year.
- Long-Term Deferred Tax rose to $75.7 million in Q4 2024 per INGN's latest filing, from $71.5 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $75.7 million in Q4 2024 and troughed at $9.2 million in Q2 2021.
- A 5-year average of $31.9 million and a median of $15.5 million in 2021 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2020 and 2023: Long-Term Deferred Tax tumbled 49.99% in 2020, then increased 27.93% in 2023.
- A 5-year view of Long-Term Deferred Tax shows it stood at $14.5 million in 2020, then climbed by 7.01% to $15.5 million in 2021, then jumped by 260.98% to $55.9 million in 2022, then advanced by 27.93% to $71.5 million in 2023, then advanced by 5.94% to $75.7 million in 2024.
- Business Quant data shows INGN's Long-Term Deferred Tax at $75.7 million in Q4 2024, $71.5 million in Q4 2023, and $55.9 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 75.74 Mn |
| Dec 31, 2023 | 71.50 Mn |
| Dec 31, 2022 | 55.88 Mn |
| Sep 30, 2021 | 15.48 Mn |
| Jun 30, 2021 | 9.17 Mn |
| Mar 31, 2021 | 15.99 Mn |
| Dec 31, 2020 | 14.47 Mn |
| Sep 30, 2020 | 14.08 Mn |
| Mar 31, 2020 | 14.65 Mn |
| Dec 31, 2019 | 14.45 Mn |
| Sep 30, 2019 | 11.18 Mn |
| Jun 30, 2019 | 26.06 Mn |
| Mar 31, 2019 | 29.30 Mn |
| Dec 31, 2018 | 30.13 Mn |
| Sep 30, 2018 | 26.28 Mn |
| Jun 30, 2018 | 20.74 Mn |
| Mar 31, 2018 | 20.43 Mn |
| Dec 31, 2017 | 18.64 Mn |
| Sep 30, 2017 | 24.62 Mn |
| Jun 30, 2017 | 25.99 Mn |